Broadcom's Q2 revenue miss has implications for tech stocks and investor sentiment. Here's what to consider.

ATN International's $268 million tower sale enhances financial flexibility, impacting its 2026 outlook positively.

Aveanna Healthcare's acquisition of Family First signals growth potential and updated guidance for investors.

As Costco approaches its earnings report, key operational metrics and premium valuation risks come into focus.

Abercrombie & Fitch's latest earnings report reveals strong domestic demand countering international sales declines, boo…

Eli Lilly's strategic $4 billion investment in vaccine development signals a major shift in its R&D focus towards infect…

Pennant Group's acquisition of a senior living community in Arizona highlights growth potential in senior care.

Collegium Pharmaceuticals enhances its ADHD portfolio through the acquisition of AZSTARYS, targeting growth in a booming…

Western Midstream's $1.6B acquisition of Brazos Delaware enhances its foothold in the Permian Basin amid ongoing midstre…

Pfizer's Q1 2026 earnings surpassed expectations, indicating a strategic shift towards diversified growth.

Pfizer exceeded Q1 estimates and reaffirmed its outlook, signaling a shift towards sustainable growth post-Covid.

Organon reports a 16% drop in Women's Health revenue, raising concerns for investors in the healthcare sector.